ALOKA unveils new flagship ProSound F75 model to European market at ISUOG 2010

New system matches ‘sound velocity’ to FIT specific organ and tissue types, giving far higher image resolutions

Zug, Switzerland – 08 October 2010 - ALOKA Holding Europe AG, is unveiling its new flagship model, the ProSound F75, at the 20th ISUOG World Congress in Prague, Czech Republic.

The F75 system has been designed with the new ALOKA ‘FIT’ ethos (Facilitated workflow; Investment return; True diagnostics) at its heart and each machine can be tailored to the needs of any clinician (with over 45 kinds of user presets). This not only simplifies the process for the clinician, but also vastly reduces patient dependency and the time taken to conduct each assessment.

What’s more, the intelligent ‘sound velocity’ adjustment alters the frequency at which the signal is passed through tissue enabling the system to be always operating at the optimal speed for different tissue densities.

The system has bespoke settings for Obstetrics and Gynecology assessments (a patient’s age, weight and stage in pregnancy), and includes a new feature to simultaneously display stored and real-time images, which is a highly useful clinical tool during follow-up appointments.

Prof. Giuseppe Rizzo a ProSound F75 user from the department of obstetrics and gynecology at the San Giovanni Calibita Hospital commented: “I was greatly impressed by the quality of this new ultrasound system from ALOKA, the ProSound F75. This premium ultrasound unit is exceptionally ergonomic and compact, and clinicians with no prior experience can be trained on all necessary functions for scanning extremely quickly and without any difficulties. B-Mode imaging is excellent in every condition, gestational age and type of patient, with extremely detailed fetal heart examinations - even in the early weeks. In addition, the eFlow+ technique is also superb and provides an excellent sensitivity, together with a high resolution, that ensures diagnostic confidence in first trimester fetal heart examinations.”

THE ALOKA ‘FIT’ principles:

F: Facilitated workflow
The ProSound F75 acknowledges the needs of performing examinations in a natural posture without stress or discomfort. The monitor and operation panel have a wide range of movement, which enables reduction of the operator's muscle load up to 20%. Another factor is automation of operation to make examinations flow smoother. The ProSound F75 allows simple operation so the operator can concentrate on the examination in comfort.

I: Investment return
The ProSound F75 covers numerous applications in one console, with its wide variety of probes, measurement/report package, and many other factors. Affordable cost of ownership is guaranteed due to the reliable system design and easy-to-upgrade software. With simple and intuitive operation, new users can easily learn to operate the system.

T: True diagnostics
By combining all of our cutting-edge technologies, the ProSound F75 performs high spatial resolution. The combination of the CPWG+ (compound pulse wave generator, the new front-end processor) and Full Aperture Apodization (uses all transducer elements of a probe) perfects focus throughout the entire image. This technology will enhance the efficiency of examinations, and will benefit both patients and examiners.

The ProSound F75 will be available for shipment in Europe from November 2010.

About ALOKA
ALOKA CO., LTD is a leading health and scientific company operating in three core areas: Medical Electronic Systems – diagnostic ultrasound; General Analytical Instruments – radiation measurement; and Clinical Laboratory Systems – specimen preprocessing. It has been the world’s leading pioneer of ultrasound systems for the medical and health science industries for nearly 60 years, providing ultrasound solutions to the Obstetrics/Gynecology, General Imaging, Internal Medicine, Cardiovascular, Surgical and Endoscopic Ultrasound fields.  

ALOKA’s worldwide headquarters are located in Tokyo, Japan, and with 40 domestic and 16 overseas business establishments, including subsidiaries; ALOKA exports its products to more than 150 countries.  With its commitment to “Illuminate the Change; See the unseen”, ALOKA is dedicated to excellence providing the systems to advance prognosis, prediction and prevention, ensuring the best quality of life for patients and society.